Prostate Cancer
Characteristics of incidental prostate cancer in the United States.
October 25, 2023
Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral zone in men without prostate cancer.
October 24, 2023
Sumitomo Pharma Announces Authorization in Canada of ORGOVYX® (relugolix) for the Treatment of Men with Advanced Prostate Cancer
October 23, 2023
PSMA-PET in Addition to mpMRI and Biopsies to Select Prostate Cancer Patients for Focal Therapy.
October 23, 2023
Long-Term Nephrotoxicity of 177Lu-PSMA Radioligand Therapy.
October 23, 2023